Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A physically transient form of silicon electronics.

Science (New York, N.Y.)·2012
Same author

An ab initio investigation of fluorobromo carbene.

The journal of physical chemistry. A·2012
Same author

[Comparison and thinking on literatures of low back pain treated with acupuncture-moxibustion published in foreign SCI journals and domestic core journals].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion·2012
Same author

[Effect of ceramide on GSTA1 in Caco-2 cells].

Yao xue xue bao = Acta pharmaceutica Sinica·2012
Same author

Association of AFF1 rs340630 and AFF3 rs10865035 polymorphisms with systemic lupus erythematosus in a Chinese population.

Immunogenetics·2012
Same author

4-{(E)-2-[4-(Diethyl-amino)-phen-yl]ethen-yl}-1-methyl-pyridin-1-ium tetra-phenyl-borate.

Acta crystallographica. Section E, Structure reports online·2012
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
See all related articles

Related Experiment Video

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Biomarkers.

Xingzhi Guo1, Rui Li1

  • 1Shaanxi Provincial People's Hospital, Xi'an, Shaanxi Provincial, China.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 24, 2025
PubMed
Summary
This summary is machine-generated.

Higher blood levels of pituitary adenylate cyclase-activating polypeptide (PACAP) are causally linked to a reduced risk of Alzheimer's disease (AD). This suggests PACAP may be a potential therapeutic target for AD.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Related Experiment Videos

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Area of Science:

  • Neuroscience
  • Genetics
  • Biomarkers

Background:

  • Pituitary adenylate cyclase-activating polypeptide (PACAP) has been implicated in Alzheimer's disease (AD) pathology.
  • The causal relationship between blood PACAP levels and AD risk is not well-established.

Purpose of the Study:

  • To investigate the potential causal effect of blood PACAP levels on Alzheimer's disease susceptibility.
  • To explore PACAP as a potential biomarker or therapeutic target for AD.

Main Methods:

  • A two-sample Mendelian randomization analysis was employed using genome-wide association study (GWAS) summary statistics.
  • Instrumental variables for blood PACAP were derived from a plasma proteome GWAS, and AD data were obtained from the International Genomics of Alzheimer's Project.
  • Multiple statistical methods and sensitivity analyses were used to ensure result robustness.

Main Results:

  • Genetically predicted higher blood PACAP levels were significantly associated with a decreased risk of Alzheimer's disease (OR=0.87, p=0.003).
  • Sensitivity analyses confirmed the robustness of the findings, with no significant evidence of pleiotropy or heterogeneity.
  • Leave-one-out analysis indicated that no single instrumental variable unduly influenced the results.

Conclusions:

  • Blood PACAP levels causally contribute to a lower susceptibility to Alzheimer's disease.
  • PACAP presents a promising avenue for AD diagnosis and therapeutic interventions.